TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 23,550 | 7,062 | 3,696 |
Financial expenses | 0 | 13 | 0 |
Earnings before taxes | 2,329 | -6,922 | -7,287 |
EBITDA | 2,385 | -6,878 | -7,273 |
Total assets | 101,783 | 101,661 | 58,282 |
Current assets | 35,998 | 44,819 | 10,738 |
Current liabilities | 7,194 | 9,427 | 6,250 |
Equity capital | 94,589 | 92,234 | 52,032 |
- share capital | 2,686 | 2,686 | 2,084 |
Employees (average) | 10 | 9 | 8 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 92.9% | 90.7% | 89.3% |
Turnover per employee | 2,355 | 785 | 462 |
Profit as a percentage of turnover | 9.9% | -98.0% | -197.2% |
Return on assets (ROA) | 2.3% | -6.8% | -12.5% |
Current ratio | 500.4% | 475.4% | 171.8% |
Return on equity (ROE) | 2.5% | -7.5% | -14.0% |
Change turnover | 16,488 | 3,366 | 2,632 |
Change turnover % | 233% | 247% | |
Chg. No. of employees | 1 | 1 | -1 |
Chg. No. of employees % | 11% | -11% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.